HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension

计划入组 64 人 · 首次发布于 2026 年 6 月 12 日

A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction

计划入组 12 人 · 首次发布于 2026 年 3 月 12 日

Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine

计划入组 220 人 · 首次发布于 2013 年 11 月 18 日

Pentabio Vaksin DTP-HB-Hib

DTwP-Hb-Hib pentavalent vaccine (Indian Immunologicals)

HJM-561

HUB

XGEN PHARMACEUTICALS DJB, INC.

United States

HLB Pharmaceutical Co., Ltd.

South Korea

Inhibrx Reports Positive Phase 1/2 Data for Ozekibart in Colorectal Cancer, Plans FDA Filing for Chondrosarcoma

Transcenta Sells Hangzhou CDMO Plant to WuXi Biologics for RMB 190 Million, Then Licenses HiCB Platform Back to the Buyer

Transcenta Licenses HiCB Continuous Bioprocessing Platform to WuXi Biologics in Strategic CMC Collaboration